Clinical Trials for Nectin Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Nectin Therapeutics

Clinical Trials (1)

NCT05378425
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
PHASE1Recruiting
90 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
5 conditions2 sponsors6 locations